Black patients with HF undertreated with SGLT2 inhibitors - Healio

Black patients with HF undertreated with SGLT2 inhibitors - Healio
PHILADELPHIA — Black patients are highly likely to benefit from prescription of SGLT2 inhibitors for HF, but they are less commonly prescribed them compared with other patients, according to a speaker. Because Black patients have high prevalence of HF, …
Source/Disclosures Source: Morris AA. Session 1: Joint Symposium with Circulation. Presented at: Heart in Diabetes; June 24-26, 2022; Philadelphia (hybrid meeting). Disclosures: Morris reports … [+4092 chars] Read More



Related Stories

See All